Use of pyridoindolone derivatives for preparing anticancer medicines

Details for Australian Patent Application No. 2002304551 (hide)

International Classifications

Event Publications

19 December 2002 Complete Application Filed

Priority application(s): 01/05843 27.04.01 FR

17 April 2003 Application Open to Public Inspection

Published as AU-B-2002304551

17 February 2005 Change of Name(s) of Applicant(s), Section 104

Sanofi-Synthelabo The name of the applicant has been changed to Sanofi-Aventis

19 April 2007 Application Accepted

Published as AU-B-2002304551

23 August 2007 Standard Patent Sealed

18 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.